MedWatch

Danish growth comet expands to the US

The Danish company Intomics, a spinout from DTU (Technical University of Denmark), continues the growth that has doubled the company’s workforce and brought in a gross profit increase of 140 percent in four years. This is according to CEO Thomas Skøt Jensen, who also reveals the plans of expanding the business to the US biotech hotspot Cambridge.

Foto: Intomics PR

CEO in Intomics, Thomas Skøt Jensen, and his colleagues were in high spirits when the Danish company once again was crowned as one of Denmark’s fastest growing companies in the business daily Børsen’s annual “Gazelle Award" honoring continuously growing companies that manage to double the revenue or gross profit during four financial years. And Intomics fully meet this criterion.

Intomics, that specializes in data analysis for the pharmaceutical and biotech industry, has increased its gross profit by 140 percent during the past four years and measured in gross profit, the company has been growing ever since it was founded in 2009.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier